Selective TBK1/IKKi dual inhibitors with anticancer potency

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|134|8|1972-1980

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.134, Iss.8, 2014-04, pp. : 1972-1980

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The efficacy of tubulin deacetylase inhibitors AGK2 and TSA

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 3, 2015-02 ,pp. : 829-840

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interleukin‐17 regulates the expressions of RANKL and OPG in human periodontal ligament cells via TRAF6/TBK1‐JNK/NF‐κB pathways

By  

IMMUNOLOGY, Vol. 144, Iss. 3, 2015-03 ,pp. : 472-485

John Wiley & Sons Inc

Access to resources Recommend Favorite

Implementation of NICE guidance on Cox-II selective inhibitors

By Arnold K.  

Journal of Clinical Excellence, Vol. 4, Iss. 3, 2002-07 ,pp. : 315-317

Radcliffe Press

Access to resources Recommend Favorite

Selective COX-2 Inhibitors and Risk of Myocardial Infarction

By  

Journal of Vascular Research, Vol. 42, Iss. 4, 2005-07 ,pp. : 312-324

Karger

Access to resources Recommend Favorite

Afferent fiber-selective shift in opiate potency following targeted opioid receptor knockdown

By Jones T.L.   Sweitzer S.M.   Wilson S.P.   Yeomans D.C.  

Pain, Vol. 106, Iss. 3, 2003-12 ,pp. : 365-371

Elsevier

Access to resources Recommend Favorite